D-0868-2023 Class I Terminated
FDA drug recall D-0868-2023 was initiated by Novis PR, LLC Dba Kramer Novis on Apr 20, 2023 and is designated Class I. Reason for recall: Product mix-up: incorrect product was found inside the G-Supress DX product carton. The recall status is terminated (terminated Sep 13, 2024). Affected quantity: 9077 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 7, 2023
- Initiation Date
- Apr 20, 2023
- Termination Date
- Sep 13, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9077 bottles
Product description
G-Supress DX (Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl) Pediatric Drops Cough Suppressant Expectorant Nasal Decongestant, Cherry Flavor Sugar & Alcohol Free, packaged in a bottle Net Content: 30 mL (1 oz.) further packaged in a carton, Manufactured in the USA for Kramer Novis, San Juan, PR 00917, NDC 52083-655-01
Reason for recall
Product mix-up: incorrect product was found inside the G-Supress DX product carton.
Distribution pattern
Puerto Rico
Code information
Lot: D20911, Exp. Oct/25
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0868-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026